Diagonal Therapeutics

Diagonal Therapeutics is a biotechnology company focused on developing agonist antibody therapies for debilitating diseases. Unlike traditional antibodies that inhibit biological processes, their approach utilizes agonist antibodies that activate critical biological pathways. The company's DIAGONAL platform utilizes proprietary computational and experimental techniques to rapidly identify and develop these agonist antibodies, enabling them to tackle diseases previously considered difficult to treat. This platform has already yielded promising drug candidates for conditions like Hereditary Hemorrhagic Telangiectasia (HHT) and Pulmonary Arterial Hypertension (PAH).

Diagonal Therapeutics has assembled a team of experienced scientific and business leaders and has secured $128 million in funding to advance its pipeline of innovative therapies. Their commitment to collaboration and their unique approach to agonist antibody development make them a promising player in the pharmaceutical industry, working to deliver life-changing treatments to patients in need.

Diagonal Therapeutics is a biotechnology company focused on advancing novel agonist antibody therapies to treat the underlying cause of debilitating diseases. Their unique platform, DIAGONAL, utilizes computational and experimental techniques to rapidly identify and develop agonist antibodies that activate critical biological pathways. This groundbreaking approach aims to provide effective treatment options for patients suffering from diseases where current therapies are limited or non-existent.

Diagonal Therapeutics cultivates a culture that values agility, inclusion, effectiveness, and accountability, fostering a nimble and cohesive team of experts dedicated to translating innovative ideas into practice. Operating with trust, respect, transparency, and integrity, they prioritize discovering medicines that positively impact patients' lives.

Diagonal Therapeutics emphasizes a commitment to building a diverse, equitable, and inclusive workplace. Their team values agility, inclusion, effectiveness, and accountability, fostering a culture of trust, respect, transparency, and integrity. This commitment is reflected in their dedication to creating medicines that positively impact patients' lives, driven by a nimble and cohesive team of experts.